Please login to the form below

Not currently logged in
Email:
Password:

BCMA

This page shows the latest BCMA news and features for those working in and with pharma, biotech and healthcare.

BMS and 2seventy bio move away from CAR-T programme

BMS and 2seventy bio move away from CAR-T programme

This cancellation is the second anti-BCMA CAR-T programme to be halted under BMS in the last twelve months, after a development programme with Juno Therapeutics was scrapped in February ... Abecma, approved in March 2021 as the first BCMA CAR-T programme,

Latest news

More from news
Approximately 7 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    The lead programme EM801 is a T cell bispecific antibody targeting B-cell maturation antigen (BCMA), which s considered to be complementary to Bluebird bio's CAR T cell therapies targeting ... BCMA to which Celgene already has access.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...